Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

ClinicalTrials.gov ID: NCT06335173

Public ClinicalTrials.gov record NCT06335173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Intravenous Sabirnetug in Early Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the efficacy of sabirnetug infusions administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's disease.

Study identification

NCT ID
NCT06335173
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Acumen Pharmaceuticals
Industry
Enrollment
542 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2024 (Actual)
Primary completion
Oct 2026 (Estimated)
Completion
Oct 2026 (Estimated)
Last update posted
Oct 27, 2025

2024 – 2026

United States locations

U.S. sites
44
U.S. states
18
U.S. cities
43
Facility City State ZIP Site status
The Neurology Center of Southern California - Carlsbad Carlsbad California 92011-4219 —
Neurology Center of North Orange County Fullerton California 92835 —
Irvine Medical Research Irvine California 92614 —
Healthy Brain Research Long Beach California 90804 —
Syrentis Clinical Research Santa Ana California 92705 —
CenExel - California Neuroscience Research Medical Group, Inc (CNR) Sherman Oaks California 91403-2131 —
Research Center for Clinical Studies, LLC Norwalk Connecticut 06851-4903 —
Re:Cognition Health - Fairfax Washington D.C. District of Columbia 22031 —
JEM Research Institute Atlantis Florida 33462 —
Bradenton Research Center Bradenton Florida 34205 —
Gil Fernandez-Yera, MD, PA Coral Gables Florida 33135 —
Brain Matters Research Delray Beach Florida 33445 —
Coral Clinical Research Homestead Florida 33032 —
K2 Medical Research - Villages Lady Lake Florida 32159 —
Finlay Medical Research Miami Florida 33126 —
Aqualane Clinical Research Naples Florida 34105-8522 —
Ocala Health - Family Care Specialists - Ocala I Ocala Florida 34470 —
Progressive Medical Research Port Orange Florida 32127 —
Alzheimer's Research and Treatment Center - Stuart Stuart Florida 34997 —
K2 Medical Research - Tampa Tampa Florida 33607 —
Charter Research - Lady Lake The Villages Florida 32162 —
Alzheimers Research and Treatment Center - Wellington Wellington Florida 33414 —
Conquest Research Winter Park Florida 32789 —
Charter Research - Winter Park Winter Park Florida 32792 —
Columbus Memory Center Columbus Georgia 31909 —
CenExel - iResearch Atlanta Decatur Georgia 30030 —
Office of Jeffrey S. Ross, MD Northbrook Illinois 60640 —
Boston Center for Memory Newton Massachusetts 02459 —
Hattiesburg Clinic - Memory Center Hattiesburg Mississippi 39401-7246 —
ActivMed Practices and Research Portsmouth New Hampshire 03801 —
The Cognitive and Research Center of New Jersey Springfield New Jersey 07081 —
CenExel - Advanced Memory Research Institute of NJ Toms River New Jersey 08755 —
Neurological Associates of Albany Albany New York 12208 —
AMC Research Matthews North Carolina 28105 —
Cleveland Clinic Cleveland Ohio 44195 —
Summit Research Network Portland Oregon 97210 —
Abington Neurological Associates Abington Pennsylvania 19001 —
Keystone Clinical Research Norristown Pennsylvania 19462 —
Rhode Island Mood and Memory East Providence Rhode Island 02914 —
Neurology Clinic. P.C Cordova Tennessee 38018 —
The Alliance for Multispecialty Research LLC (AMR) Knoxville Tennessee 37920-1511 —
Senior Adult Specialty Research Austin Texas 78757 —
Gadolin Research, LLC Beaumont Texas 77702 —
Kerwin Medical Center Dallas Texas 75231 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06335173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06335173 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →